Disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in Japan in early diagnostic stages and associated factors: a cross-sectional study.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Hiroyuki Sato, Misao Fujita, Atsushi Tsuchiya, Taichi Hatta, Katsumi Mori, Eisuke Nakazawa, Yoshiyuki Takimoto, Akira Akabayashi
{"title":"Disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in Japan in early diagnostic stages and associated factors: a cross-sectional study.","authors":"Hiroyuki Sato,&nbsp;Misao Fujita,&nbsp;Atsushi Tsuchiya,&nbsp;Taichi Hatta,&nbsp;Katsumi Mori,&nbsp;Eisuke Nakazawa,&nbsp;Yoshiyuki Takimoto,&nbsp;Akira Akabayashi","doi":"10.1186/s13030-022-00247-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>With a recent increase in the prevalence of autism spectrum disorder (ASD), an important issue has emerged in clinical practice regarding when and how patients themselves should be given explanations following a diagnosis of ASD. The clinical guidelines of the UK National Institute for Health and Care Excellence state that children diagnosed with ASD should receive an explanation about what ASD is and how it affects their development and functioning-\"if appropriate\". However, the guidelines do not provide any specifics regarding what constitutes \"appropriate\" situations METHODS: We conducted an anonymous self-administered postal questionnaire survey targeting all members of the Japanese Society for Child and Adolescent Psychiatry (n=1,995). The analysis included only physicians who had newly diagnosed pediatric patients with ASD in the past year. We imposed a limit of one year because diagnoses further back than that are difficult to recall; in other words, this would enhance the recall bias RESULTS: The recovery rate was 30.8%, and the rate of diagnosis disclosure to patients themselves without intellectual disability was 15.3%. We asked 361 physicians who responded that \"deciding on a case-by-case basis\" was the ideal way to disclose an ASD diagnosis about 20 items prioritized by physicians at the time of diagnosis disclosure and extracted three factors through exploratory factor analysis. Multiple logistic regression analysis was performed with physician attributes, awareness of ASD as a disorder or personality, and the three extracted factors as explanatory variables; diagnosis disclosure was the dependent variable. The patient age group and only one of the three factors (i.e., \"factor related to readiness to accept diagnosis\") showed a significant association with disclosure of the diagnosis to the individual. Items included in the \"factor related to readiness to accept diagnosis\" were as follows: the degree of parental understanding, relationship of the patient with their parents/physician, agreement in opinion between parents, parental consent, \"sufficient\" patient understanding, symptom stabilization, and a guarantee of sufficient time required to explain the diagnosis to the patient CONCLUSION: In clinical settings, disclosing an ASD diagnosis with the consideration of patient/parent readiness toward accepting the diagnosis could help to guide physicians in determining an ideal timing for disclosure. Future studies are needed to establish detailed and concrete guidelines regarding disclosure of an ASD diagnosis to patients.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2022-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391641/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13030-022-00247-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: With a recent increase in the prevalence of autism spectrum disorder (ASD), an important issue has emerged in clinical practice regarding when and how patients themselves should be given explanations following a diagnosis of ASD. The clinical guidelines of the UK National Institute for Health and Care Excellence state that children diagnosed with ASD should receive an explanation about what ASD is and how it affects their development and functioning-"if appropriate". However, the guidelines do not provide any specifics regarding what constitutes "appropriate" situations METHODS: We conducted an anonymous self-administered postal questionnaire survey targeting all members of the Japanese Society for Child and Adolescent Psychiatry (n=1,995). The analysis included only physicians who had newly diagnosed pediatric patients with ASD in the past year. We imposed a limit of one year because diagnoses further back than that are difficult to recall; in other words, this would enhance the recall bias RESULTS: The recovery rate was 30.8%, and the rate of diagnosis disclosure to patients themselves without intellectual disability was 15.3%. We asked 361 physicians who responded that "deciding on a case-by-case basis" was the ideal way to disclose an ASD diagnosis about 20 items prioritized by physicians at the time of diagnosis disclosure and extracted three factors through exploratory factor analysis. Multiple logistic regression analysis was performed with physician attributes, awareness of ASD as a disorder or personality, and the three extracted factors as explanatory variables; diagnosis disclosure was the dependent variable. The patient age group and only one of the three factors (i.e., "factor related to readiness to accept diagnosis") showed a significant association with disclosure of the diagnosis to the individual. Items included in the "factor related to readiness to accept diagnosis" were as follows: the degree of parental understanding, relationship of the patient with their parents/physician, agreement in opinion between parents, parental consent, "sufficient" patient understanding, symptom stabilization, and a guarantee of sufficient time required to explain the diagnosis to the patient CONCLUSION: In clinical settings, disclosing an ASD diagnosis with the consideration of patient/parent readiness toward accepting the diagnosis could help to guide physicians in determining an ideal timing for disclosure. Future studies are needed to establish detailed and concrete guidelines regarding disclosure of an ASD diagnosis to patients.

Abstract Image

日本儿科患者在早期诊断阶段披露无智力障碍的自闭症谱系障碍诊断及其相关因素:一项横断面研究
背景:随着近年来自闭症谱系障碍(ASD)患病率的增加,临床实践中出现了一个重要的问题,即在诊断为ASD后,何时以及如何向患者自己解释。英国国家健康和护理卓越研究所的临床指南指出,被诊断患有自闭症谱系障碍的儿童应该得到一个关于自闭症谱系障碍是什么以及它如何影响他们的发育和功能的解释——“如果合适的话”。方法:我们对日本儿童和青少年精神病学协会的所有成员(n= 1995)进行了一项匿名的、自我管理的邮寄问卷调查。该分析仅包括在过去一年中新诊断出患有自闭症的儿科患者的医生。我们设定了一年的限制,因为更早的诊断很难回忆起来;结果:康复率为30.8%,对自身无智力障碍患者的诊断披露率为15.3%。我们询问了361名医生,他们回答“根据具体情况决定”是披露ASD诊断的理想方式,其中包括医生在披露诊断时优先考虑的20个项目,并通过探索性因素分析提取了三个因素。以医师属性、对ASD作为一种障碍或人格的认识以及提取的三个因素作为解释变量进行多元logistic回归分析;诊断披露为因变量。患者年龄组和三个因素中只有一个(即“与接受诊断的准备程度相关的因素”)与向个人披露诊断有显著关联。“准备接受诊断的相关因素”包括:父母理解程度、患者与父母/医生的关系、父母意见的一致性、父母同意、患者“充分”理解、症状稳定、保证有足够的时间向患者解释诊断。在临床环境中,在考虑患者/家长是否愿意接受诊断的情况下披露ASD诊断,可以帮助指导医生确定披露的理想时机。未来的研究需要建立关于向患者披露ASD诊断的详细和具体的指导方针。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信